RxDoctor Payments Data

Barbara Terpstra, MD

Phlebology · Orland Park, ILNPI 1396945184

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Koya Medical, Inc. at 45.2% of the total. Reporting peaked in 2024 at $300 and has fallen 69.4% since, to $92 in 2025.

$733in general payments, 2019–2025

Across 23 payments — averaging $31.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Koya Medical, Inc.$331
  • Tactile Systems Technology Inc$143
  • Boston Scientific$64
  • E.r. Squibb & Sons, L.L.C.$62
  • Organogenesis Inc.$38
  • Angiodynamics, Inc.$27
  • plus $69 from 3 others

What the payments were for

  • Food & beverage$733100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Koya Medical, Inc.3$331
Tactile Systems Technology Inc8$143
Boston Scientific3$64
E.r. Squibb & Sons, L.L.C.3$62
Organogenesis Inc.2$38
Angiodynamics, Inc.1$27
Medtronic1$27
Biocompatibles, Inc.1$23
Cashflow Solutions, LLC1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few phlebology providers in Illinoisto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$291,435
Medicare patients
180
Services billed
1,139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other phlebology in Orland Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →